Approval · Notice of Compliance 10906 · 2010
RAMIPRIL: Notice of Compliance 10906
Issued January 12, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10906
- Date
- January 12, 2010
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- ALTACE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAMIPRIL | 02340216 | — |
| RAMIPRIL | 02340224 | — |
| RAMIPRIL | 02340232 | — |
| RAMIPRIL | 02340240 | — |